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Abstract 
Background: Owing to the use of tobacco and the consumption of alcohol and adulterated food, worldwide cancer 
incidence is increasing at an alarming and frightening rate. Since the last decade of the twentieth century, lung can-
cer has been the most common cancer type. This study aimed to determine the global status of lung cancer and to 
evaluate the use of computational methods in the early detection of lung cancer.
Methods: We used lung cancer data from the United Kingdom (UK), the United States (US), India, and Egypt. For 
statistical analysis, we used incidence and mortality as well as survival rates to better understand the critical state of 
lung cancer.
Results: In the UK and the US, we found a significant decrease in lung cancer mortalities in the period of 1990–2014, 
whereas, in India and Egypt, such a decrease was not much promising. Additionally, we observed that, in the UK and 
the US, the survival rates of women with lung cancer were higher than those of men. We observed that the data min-
ing and evolutionary algorithms were efficient in lung cancer detection.
Conclusions: Our findings provide an inclusive understanding of the incidences, mortalities, and survival rates of 
lung cancer in the UK, the US, India, and Egypt. The combined use of data mining and evolutionary algorithm can be 
efficient in lung cancer detection.
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Background
Worldwide, lung cancer is the leading cause of cancer-
related death. However, according to the latest medi-
cal research reports [1–3], if the nature and symptoms 
of cancer are correctly identified at an early stage, it can 
be cured. The cancer spreads to other parts of the body 
through the blood and lymphatic system, which is a pro-
cess called metastasis, and then quickly causes the devel-
opment of secondary tumors [4]. Some high-risk factors 
like smoking, breathing polluted air, and living in a pol-
luted area can negatively affect the prognosis and quality 
of life of lung cancer patients [1, 5]. Lung cancer can also 
be hereditary [2].
At the beginning of the twentieth century, the inci-
dence of lung cancer was very low, but now its incidence 
is increasing rapidly [4, 6]. According to the GLOBO-
CAN 2012 report, there have been 1.8 million new cases 
(incidence) of lung cancer globally, constituting 12.9% of 
the total estimated cancer incidence in the year 2012 [2]. 
Of these cases, 58.0% are from the underdeveloped coun-
tries [2]. Hungary had the highest incidence of lung can-
cer (51.6%), followed by Serbia (45.6%) and Korea (44.2%) 
[2]. In 2012, lung cancer incidences for both men and 
women were highest in North America; the incidences 
were lowest in Africa, followed by Latin America and the 
Caribbean. In the same year, incidence of lung cancer in 
men was highest in Hungary (76.6%), followed by Arme-
nia (72.9%) and Macedonia (44.2%) [2]. In India, the lung 
cancer mortality is high [7]. In 2012, the World Health 
Organization (WHO) reported that, worldwide, lung 
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cancer causes 1.59 million deaths [8]. Tobacco-smokers 
aged above 50 years are at the highest risk for lung can-
cer. Presently, incidence of lung cancer is low in women, 
but changes in lifestyle might increase it in the future.
Based on the aforementioned data, it is clear that the 
worldwide incidence of lung cancer is alarming; indeed, 
it has become the most common and fatal type of cancer. 
The main objectives of this study were to assess the inci-
dence of lung cancer and the associated mortality, and 
to analyze the on-going research in the field of compu-
tational methods for lung cancer detection. An in-depth 
analysis of the current research will be helpful in the 
development of new techniques to detect lung cancer at 
an early stage.
Data sources and methods
For this study, we collected data on lung cancer incidence 
and mortality in the United Kingdom (UK), the United 
States (US), India, and Egypt from the following sources 
[3]. We have also considered data sources from France 
and Switzerland, as these organizations collect and pub-
lish global data.
UK
General Register Office for Scotland: A repository that 
maintains medical statistics and records of births and 
deaths.
Information Services Division (ISD), Scotland: Part of 
National Services Scotland. Provides health data to all, 
free of charge.
National Cancer Intelligence Network (NCIN): Estab-
lished to improve clinical outcomes, cancer care, and pre-
vention. Since April 2013, part of Public Health England.
Northern Ireland Cancer Registry: Established in 1994 
and located in the Centre for Public Health, Queen’s Uni-
versity Belfast. Maintains cancer incidence and mortality 
data. Funded by the Public Health Agency for Northern 
Ireland.
Northern Ireland Statistics and Research Agency: 
A repository that maintains medical data and social 
research as well as records of deaths and births.
Office for National Statistics (ONS): A statistical insti-
tute of the UK. Collects and publishes population, social, 
and economic statistics.
United Kingdom and Ireland Association of Cancer 
Registries (UKIACR): Focuses on developing cancer reg-
istration in the UK and Ireland for the purpose of study-
ing and controlling cancer.
Welsh Cancer Intelligence and Surveillance Unit 
(WCISU), Wales: The national cancer registry of Wales. 
Stores and publishes data on cancer incidences in 
Wales.
US
Centers for Disease Control and Prevention (CDC): It 
helps in detecting and responding to new and emerging 
health threats. The aim of CDC is to tackle the biggest 
health problems that cause disability and death.
Surveillance, Epidemiology, and End Results (SEER) 
database: An authoritative source of information on can-
cer incidence and survival in the US.
India
Indian Cancer Society (ICS): A non-profit organization 
established by Dr. Darab Jehangir Jussawalla and Mr. 
Naval Tata for cancer awareness, detection, cure, and 
survival. Also gathers cancer-related incidence and mor-
tality data from different cities in India.
Indian Council of Medical Research (ICMR): A council 
in New Delhi, India, for the preparation, collocation, and 
support of biomedical research. Main research focus is to 
control communicable diseases, cancer, cardiovascular 
diseases, blindness, and diabetes and to develop health-
care strategies. Launched the National Cancer Registry 
Program (NCRP) to collect reliable cancer data, conduct 
epidemiologic studies, design cancer control strategies, 
and organize cancer awareness programs.
Institute of Cytology and Preventive Oncology (ICPO): It 
is a leading institute under the ICMR. It provides aware-
ness, prevention strategies, and treatments of leading 
cancers in India.
Egypt
Gharbiah Population-based Cancer Registry (GPCR): 
Sponsored by the Middle East Cancer Consortium and 
the Egyptian Ministry of Health. Publishes annual statis-
tics of cancer incidence and mortality as well as possible 
control strategies.
International Association of Cancer Registries (IACR): 
A professional society that collects cancer-related inci-
dence, mortality, and survivorship data for a specific pop-
ulation group.
National Cancer Registry Program of Egypt (NCRP): 
Supported by the Egyptian Ministry of Communica-
tions and Information Technology. Collects cancer data, 
conducts data analysis, operates training programs, and 
develops cancer control strategies.
Other countries
World Health Organization (WHO), Switzerland: Estab-
lished in 1948 in Geneva, Switzerland. Part of the United 
Nations. Dedicated to all matters of global health.
International Agency for Research on Cancer (IARC), 
France: A specialized cancer research agency of the 
WHO. Develops and enhances cancer prevention 
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measures, identifies malignancies at the earliest pos-
sible stage, and publishes periodic reports on cancer 
incidence.
GLOBOCAN 2014, France: A project of the IARC and 
the WHO. Estimates cancer incidence, mortality, and 
prevalence at the national level for 184 countries.
Systematic procedures and methods, surveys, and 
existing studies yield epidemiologic indicators that are 
capable of showing the process and the outcomes of 
a disease. Based purely on calculations and numerical 
information, quantitative indicators or methods can be 
useful. Useful quantitative indicators include incidence, 
prevalence, and mortality. Incidence measures new cases 
of lung cancer in the present population, whereas mor-
tality is the estimate of deaths due to lung cancer in the 
total population [9, 10]. In this study, we used incidence 
and mortality to elucidate the effects of lung cancer on 
the population.
Incidence was calculated by using the formula as fol-
lows [2, 9, 10]:
Incidence = (LCCCP/TPRCP) × 10N
LCCCP = Number of new lung cancer cases in the cur-
rent period
TPRCP  =  Number of total population at risk in the 
current period
N = 1, 2, 3…. [Sample population]
Mortality was calculated using the formula [2, 9, 10]:
Mortality = (DCCP/TPCP) × 10N
DCCP = Number of death cases in the current period
TPCP  =  Number of total population in the current 
period
N = 1, 2, 3…. [Sample population].
The current period means the years considered for the 
calculation of incidence and mortality.
Knowing the cancer survival rate in a given population 
enables researchers to estimate cancer trends and pat-
terns as well as people’s fitness levels. Net survival shows 
the probability of surviving cancer without considering 
death from other causes. Since net survival is not influ-
enced by other causes, it gives reliable results [11]. Two 
general approaches were used to estimate net survival: 
specific survival and relative survival. Specific survival 
is calculated from causes of cancer deaths [11] and is 
used mainly for clinical trials. According to Parkin et al. 
[12], sometimes the cause of death may be unavailable or 
unreliable; in such a case, it is not possible to correctly 
estimate survival. However, survival from other diseases 
can be helpful in finding the survival status of the patient 
with the disease under study by finding the differences 
between the other diseases and the total occurrences. It 
can be calculated by relative survival [12].




Expected survival can be calculated by Ederer I, Edere 
II, and Hakulinen methods. In this study, we used net 
survival and relative survival rates.
Results
Lung cancer epidemiology in the UK
We first considered the incidence and mortality of lung 
cancer in the UK during the period 1975–2014. These 
data were based on age-adjusted or age-standardized 
rates. Age-adjusted rates eliminate age bias, allowing reli-
ability when different population groups are compared. 
Incidence and mortality varied between populations 
based on age, race, sex, and demographic factors. There-
fore, we compared population groups of varying ages 
from different countries and cities.
Table 1 shows the lung cancer incidence and mortality 
in the UK during the years 1975–2014 [13–19]. Incidence 
and mortality were based on the European age-standard-
ized rate per 100,000 people in the UK. For men, lung 
cancer incidence increased in 1975–1980 and gradu-
ally decreased during 1985–2014, whereas the mortality 
gradually decreased during 1975–2014. For women, lung 
cancer incidence and mortality moderately increased 
during 1975–2014. Many factors, such as age, genetics, 
pollution and radiation levels, and lifestyle, can affect the 
development of lung cancer [20–22]. In the UK, smoking 
was the principal cause of lung cancer; 86.0% of lung can-
cer cases were associated with smoking [23, 24].
Figures 1, 2, 3 and 4 illustrate the survival rates of men 
and women with lung cancer in the UK during the period 
1971–2011 [13, 14, 16, 17, 25, 26]. Figure 1 shows that the 
1-year survival rate increased from 16.2% to 30.4% for 
men and from 15.4% to 35.1% for women. Figure 2 shows 
that, for men, the 5-year survival rate increased from 4.8% 
to 8.4% in the period 1971–2011; for women, the 5-year 
survival rate increased from 4.4% to 11.6% in the same 
Table 1 Age-standardized rates of  lung cancer incidence 
and mortality in the United Kingdom (1975–2014)




Men Women Men Women
1975 111.9 22.6 107.9 21.5
1980 113.2 28.1 106.6 25.6
1985 109.8 33.3 100.1 28.8
1990 86.7 34.3 87.7 30.5
1995 81.4 35.3 72.8 30.5
2000 70.5 36.5 60.5 29.8
2005 63.0 38.0 53.1 30.3
2010 59.2 40.5 48.0 31.4
2011–2014 58.2 40.8 47.3 31.1
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period. Figure  3 shows that, for men and women in the 
UK with lung cancer, the 10-year survival rate increased 
from 3.2% to 4.0% and from 2.9% to 6.5%, respectively, in 
the period 1971–2011. Figure 4 shows that, in the period 
2007–2011, the survival rate of men and women in the 
UK with lung cancer gradually decreased from 38.4% to 
4.8% and from 45.0% to 5.0%, respectively, with increasing 
age. Survival of lung cancer patients in the UK remained 
poor due to (i) late identification of symptoms, (ii) non-
availability of optimal treatment to most patients, (iii) lack 
of efficient screening programs, and (iv) co-occurrence 
with obesity and smoking [27, 28].
Fig. 1 One-year net survival trends of lung cancer patients in the United Kingdom (UK). During the period 1971–2011, the 1-year age-standardized 
(age 15–99 years) net survival rates of men with lung cancer increased from 16.2% to 30.4%; for women, the survival rate increased from 15.4% to 
35.1% during the same period
Fig. 2 Five-year net survival trends of lung cancer patients in the UK. During the period 1971–2011, the 5-year age-standardized (age 15–99 years) 
net survival rates of men with lung cancer has increased from 4.8% to 8.4%; for women, the survival rate increased from 4.4% to 11.6% during the 
same period
Page 5 of 13Dubey et al. Chin J Cancer  (2016) 35:71 
Lung cancer epidemiology in the US
Next, we examined lung cancer incidence and mortality 
in the US during the period 1975–2014 [29–31]. As with 
the data from the UK, the lung cancer data from the US 
were analyzed considering the age-adjusted or age-stand-
ardized rates, and SEER database incidences. For men, 
the lung cancer incidence increased during 1975–1980 
and then gradually decreased during the period 1985–
2014 (Table  2). However, mortality gradually increased 
during 1975–1990 and decreased moderately during 
1995–2014 (Table  3). For women, the incidence of lung 
cancer slowly increased during 1975–2005, whereas the 
mortality first increased gradually during 1975–2000 and 
sharply thereafter.
Figure 5 shows the 1-year survival rates [32]. For men 
and women in the US, the 1-year lung cancer survival 
rate increased from 33.4% to 40.7% and from 40.4% to 
48.5%, respectively, over the period 1975–2010. Figure 6 
Fig. 3 Ten-year net survival trends in the UK. During the period 1971–2011, the 10-year age-standardized (age 15–99 years) net survival rates of 
men with lung cancer increased from 3.2% to 4.0%; for women, the survival rate increased from 2.9% to 6.5% during the same period
Fig. 4 Five-year net survival rate of lung cancer patients by age in the United Kingdom (UK). During the period 2007–2011, the 5-year age-stand-
ardized net survival rates of men with lung cancer gradually decreased from 38.4% to 4.8%; for women, it decreased from 45.0% to 5.0%. This shows 
that the 5-year survival for lung cancer is highest in the youngest men and women and decreases with increasing age
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Table 2 Age-adjusted rate of lung cancer incidence in the United States (1975–2014)
Year All races (per 100,000 people) Whites (per 100,000 people) Blacks (per 100,000 people)
Both sexes Men Women Both sexes Men Women Both sexes Men Women
1975 52.2 89.5 24.5 51.9 89.1 24.8 64.5 114.9 24.7
1980 60.7 99.9 32.2 59.4 97.7 32.3 86.6 151.3 38.2
1985 64.6 98.6 40.2 63.9 96.9 40.9 89.6 149.7 46.0
1990 68.0 96.9 47.8 68.2 96.1 48.9 86.8 137.1 52.1
1995 66.8 89.8 50.4 67.1 87.9 52.4 85.8 138.7 50.0
2000 64.1 82.1 51.2 64.6 80.8 53.2 80.1 114.2 57.3
2005 62.9 75.7 53.7 63.9 75.5 55.7 74.4 97.7 59.2
2010 57.2 67.5 49.7 58.4 67.2 51.8 66.2 85.0 53.9
2011–2014 55.5 64.8 48.6 56.4 64.4 50.7 64.6 85.3 51.0
Table 3 Age-adjusted rate of lung cancer mortality in the United States (1975–2014)
Year All races (per 100,000 people) Whites (per 100,000 people) Blacks (per 100,000 people)
Both sexes Men Women Both sexes Men Women Both sexes Men Women
1975 42.6 76.3 17.5 42.0 75.4 17.6 49.3 91.0 17.3
1980 49.4 84.7 24.1 48.7 83.2 24.2 59.1 106.6 24.5
1985 54.3 88.5 30.4 53.6 86.6 30.8 65.7 117.5 29.6
1990 58.8 90.5 36.8 58.1 88.4 37.3 72.0 125.1 36.4
1995 58.3 84.3 40.2 58.0 82.6 40.9 69.2 116.0 38.8
2000 55.8 76.4 41.1 55.9 75.4 42.0 63.7 100.8 39.6
2005 52.8 69.4 40.7 53.3 69.0 41.7 58.5 86.9 40.1
2010 47.4 60.0 37.9 48.1 59.9 39.1 51.1 73.5 36.2
2011–2014 46.0 57.8 37.0 46.7 57.8 38.1 49.3 70.0 35.4
Fig. 5 One-year relative survival trends of lung cancer patients in the United States (US). During the period 1975–2010, 1-year relative survival rate 
for men with lung cancer increased from 33.4% to 40.7%; for women, it increased from 40.4% to 48.5%
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shows that in the US, the 5-year survival rate of male 
and female lung cancer patients increased from 11.1% 
to 15.1% and from 16.1% to 20.2%, respectively, during 
the period 1975–2006. In the year 2012, approximately 
402,326 Americans had lung cancer [32]. The CDC esti-
mated 221,220 new cases of lung cancer in 2015, repre-
senting 13.0% of all diagnosed cases of cancer [30]. Some 
studies showed that the chances of a person developing 
lung cancer depend on many factors, such as past or 
current smoking status, age, and sex [32]. Male smok-
ers were at 23-times higher risk of lung cancer than male 
non-smokers; similarly, female smokers were at 13-times 
higher risk of lung cancer than female non-smokers [33].
As shown in Table  4, a 60-year-old man has a prob-
ability of 1.9% of developing lung cancer over the next 
10 years; the corresponding probability for a 60-year-old 
woman is only 1.5% [34].
Lung cancer epidemiology in India and Egypt
Further, we examined lung cancer incidence and mortal-
ity in India during the period 1980–2014 considering the 
age-standardized rate (Table 5) [2, 7, 35, 36]. The availa-
bility of these data from India was limited. The incidence 
of lung cancer for both men and women increased during 
1980–2014.
Finally, we examined lung cancer incidence and mor-
tality in Egypt during the period 2000–2014. As in India, 
lung cancer incidence and mortality data were scarce in 
Egypt. Table 6 compiles the available data [2, 7, 37–39]. 
In Egypt, the mortality of lung cancer increased between 
2000 and 2014; smoking was the main risk factor of lung 
cancer in Egyptians also [7, 37–39].
In the present study, we reviewed approximately 110 
articles published by Elsevier, IEEE, and Springer during 
the period 2007–2015. We found that data mining and 
evolutionary algorithms were capable in efficiently clas-
sifying lung cancer data as depicted in Fig. 7. Previously, 
data mining methods were used alone by many research-
ers; however, our study indicated that the combination 
of data mining and evolutionary algorithms were more 
effective for the detection of lung cancer.
Discussion
We found that currently the incidence and mortality 
patterns of lung cancer closely follow each other at the 
global level. In the US and the UK, advanced technol-
ogy and awareness programs have helped decrease the 
mortality from lung cancer; however, this is not the case 
in India and Egypt, where more effective steps, such as 
development of special awareness programs, are required 
to decrease lung cancer mortality.
Cancer epidemiology is the study of causes and risk 
factors of a cancer for a given population. It can be help-
ful by allowing (i) the identification of health problems 
related to cancer, (ii) the measurement of the spread of 
the disease in a community, (iii) the expansion of knowl-
edge about the risk factors of cancer, and (iv) a better 
understanding of the effects of cancer.
Cancer epidemiology can provide insights into the 
causes of cancer. However, the area under an epidemio-
logic investigation is often limited to a particular region 
and usually involves a small sample size. Since cancer 
epidemiology is analytical in nature, additional com-
putational methods are required. Sample size can be 
Fig. 6 Five-year relative survival trends of lung cancer patients over time in the US. The 5-year relative survival rate of men with lung cancer 
increased from 11.1% to 15.1%; for women, it increased from 16.1% to 20.2%
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increased easily, which can yield better classification 
results.
Data mining techniques can provide better classifica-
tion and categorization of data, but these techniques 
may not efficiently cluster, classify, and predict the trends 
of sequential and time series data; hence, evolutionary 
algorithms are used to obtain optimal solutions in such 
cases. Evolutionary algorithms can produce high-quality 
analytical solutions and can simplify the problems during 
different iterative stages. Evolutionary algorithms such as 
ant colony optimization (ACO), particle swarm optimi-
zation (PSO), and artificial bee colony (ABC) are benefi-
cial as these algorithms are capable of achieving a nearer 
solution in comparison to that achieved by the use of 
data mining techniques alone.
Pattern finding is very important in cancer detection. 
For this, data mining methods are needed. Data mining 
is a procedure by which pertinent patterns can be sepa-
rated from large databases [40]. According to Jain et  al. 
[41], data mining can be used for six specific tasks: classi-
fication, estimation, prediction, association rule mining, 
clustering, and visualization. Classification, estimation, 
and prediction are examples of supervised learning. The 
primary aim of these techniques is to prepare a model 
based on the available data, which can represent one or 
more attributes. Association rule mining, clustering, and 
visualization are examples of unsupervised learning. The 
primary aim of these techniques is to establish relation-
ships between attributes. The six methods are used in 
nearly every area of healthcare databases for knowledge 
discovery, classification, and prediction. Of them, asso-
ciation rule mining, classification, and clustering are the 
most commonly used data mining techniques. These 
methods may provide a real solution for discovering 
similar types of groups, group patterns, the frequency of 
items present in the groups, the extraction of significant 
patterns, and pattern visualization [42]. Since lung cancer 
symptoms are not the same in every patient, it is essential 
to characterize their distinctive features and give unique 
treatments to different patients. In this regard, clustering 
or classification techniques may be useful because sev-
eral factors, such as age, sex, genetics, alcohol consump-
tion, smoking status, and weight may contribute to lung 
cancer.
According to Dass et al. [43], the two most important 
factors in cancer treatment are classification and charac-
terization. They successfully achieved all the classifica-
tion rules by using Apriori algorithm, which is helpful in 
Table 4 Estimated probability of  developing lung cancer in  men and  women in  the United States 10, 20, and  30  years 
later according to their current ages (2010–2012)
NA Not available
Current age (years) Lung cancer risk (%)
10 years 20 years 30 years
Men Women Men Women Men Women
30 0.0 0.0 0.1 0.1 0.8 0.7
40 0.1 0.1 0.8 0.7 2.5 2.1
50 0.6 0.5 2.5 2.0 5.3 4.2
60 1.9 1.5 5.0 3.8 7.0 5.4
70 3.5 2.6 5.9 4.4 NA NA
Table 5 Age-adjusted rates of  lung cancer incidence 
and mortality in India (1980–2014)
NA Not available




Men Women Men Women
1980 11.6 1.8 NA NA
1985 11.2 1.3 NA NA
1990 14.1 3.0 NA NA
1995 13.0 3.7 NA NA
2000 10.0 4.2 NA NA
2005 10.7 5.0 NA NA
2010 47.1 11.4 41.3 9.7
2011-2014 53.7 16.5 48.6 15.0
Table 6 Age-adjusted rates of  lung cancer incidence 
and mortality in Egypt (2000–2014)
NA Not available




Men Women Men Women
2000 11.9 3.7 NA NA
2005 14.0 3.0 NA NA
2010 9.6 2.5 9.1 2.3
2011–2014 36.3 13.8 32.4 12.4
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the diagnosis of and the drug development for squamous 
cell cancer (SCC) and adenocarcinoma (ADC) [43]. Rajan 
et al. [44] suggested that the early diagnosis of lung cancer 
is mainly dependent on its historical data. Using associa-
tion rule mining, Agrawal et al. [45] identified hotspots in 
lung cancer SEER data. A prototype mortality risk calcu-
lator was developed in this study; and the obtained rules 
satisfied biomedical knowledge. According to Yadav et al. 
[46], the detection of lung cancer is difficult at an early 
stage because it depends on multiple attributes. They 
used clustering approach for analyzing dataset from San-
jay Gandhi Post Graduate Institute of Medical Science, 
Lucknow, India. They compared the traditional cluster-
ing with foggy clustering method and achieved better 
results by using the latter. Piedra et al. [47] suggested text 
mining for a better understanding of the diagnostic pro-
cess, classification accuracy, and disease facts; this can 
also be helpful in predictive model design, alert system, 
and decision-making process. Nahar et al. [48] used the 
association rule mining for identifying risk factors in dif-
ferent types of cancer. For this, they used three different 
types of association rule mining algorithms: the Apriori, 
predictive Apriori, and tertius algorithms. The Apriori 
algorithm outperforms the other algorithms. Accord-
ing to Wang et al. [49], Bayesian network is a very useful 
method for understanding cancer metastasis. The study 
included 50,000 cancer patients from Taiwan, China, 
between 1996 and 2010. Sensitivity and specificity meas-
ures were compared based on three different approaches, 
namely naive Bayes, logistic regression, and support vec-
tor machine (SVM), but the researchers did not find sig-
nificant differences in terms of accuracy and specificity 
of the results. The interpretation capabilities of naive 
Bayes were superior to those of the other approaches, 
and it was also efficient in cases of missing information, 
modeling of non-linear situations, and stochastic medical 
problems. In their study, Krishnaiah et al. [50] examined 
decision tree, naive Bayes, and artificial neural network. 
One dependency-augmented naive Bayes classifier and 
one naive creedal classifier 2 were used for data pre-
processing and decision making purposes, and the pre-
diction results were better than the traditional methods. 
According to Phillips-Wren et  al. [51], when decision 
tree and artificial neural network were used in combi-
nation, the chances of good prediction results became 
high. Debnath et  al. [52] proposed a new evolutionary 
method for efficient classification of lung cancer genes. 
When a smaller number of genes were selected, this 
method provided better classification accuracy. Accord-
ing to Esfandiari et  al. [53], data mining can determine 
the frequency of the task at a specified time. According 
to their study, data mining can be applied for disease pre-
diction by data pre-processing and data modeling. Bal-
achandran et al. [54] performed data mining to conduct 
a systematic study of lung cancer. The data were collected 
from medically confirmed and diagnosed patients. Their 
results showed that training-based approaches such as 
neural network performed better than cross-validation 
approaches. Fung et al. [55] proposed a new classifier that 
combined the impact factors (IFs) method and Golub and 
Slonim (GS) method with k-nearest neighbour (KNN). 
They achieved good classification performance for lung 
and prostate cancer data. Kushwah et al. [56] used neu-
ral network with random forest tree classifier for cancer 
Fig. 7 Percentage of different methods used in lung cancer diagnosis. It shows the frequency of data mining methods and evolutionary algorithms 
used for lung cancer diagnosis, as reported in references [43–70]
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gene selection. According to their results, classification 
capability could be increased with the help of trained 
neural networks. Guo et  al. [57] used a network-based 
method on 164 smokers to identify the genes associated 
with smoking. They identified genes associated with lung 
cancer survival and genes that could distinguish smokers 
and non-smokers; the accuracy of the method was 73.0%. 
Ahmed et al. [58] prepared a database of 400 patients that 
comprised patients with or without cancer. For pre-pro-
cessing, k-means clustering was used. The results proved 
that this method was efficient in lung cancer risk iden-
tification. Sun et al. [59] suggested that the SVM can be 
used for lung cancer classification, based on the compari-
son of different algorithms, such as boosting, decision 
tree, and KNN. Oztekin et al. [60] proposed a prediction 
model based on decision tree, neural network, and logis-
tic regression. The study suggested that these algorithms 
were capable of accurate classification of the lung cancer 
dataset.
Evolutionary algorithms are population-based meta-
heuristic optimization algorithms that are inspired by 
nature. The principal evolutionary algorithms are genetic 
algorithm (GA), ACO, PSO, ABC, and memetic algo-
rithm. Now, evolutionary algorithms, in combination 
with the previously discussed methodologies, are being 
discussed. These algorithms can locate the closest solu-
tion even when dealing with complex issues.
Li et  al. [61] proposed a bionic enhancement calcu-
lation-based system, termed ant colony optimization-
selection (ACO-S) for high-dimensional datasets. The 
outcomes demonstrated that ACO-S could produce a 
high-quality subset with a small size and better charac-
terization. Yu et  al. [62] recommended ACO sampling 
to address the issue of class unevenness. The methodol-
ogy resulted in greater grounded speculation capacity as 
compared with the traditional methods. Sowmiya et  al. 
[63] suggested neural network and fuzzy logic to train 
data. Then, by using ACO, classification accuracy was 
improved. Alba et al. [64] compared PSO and GA. They 
used SVM in combination with either of the algorithms 
on high-dimensional microarray data for classification. 
The combination of PSO and SVM was capable of find-
ing interesting genes. Minimum redundancy maximum 
relevance (MRMR)-GA was compared with GA-SVM 
wrapper and MRMR filter. In terms of selection and 
classification performance, MRMR-GA produced better 
results. Qasem et  al. [65] presented a new multi-objec-
tive algorithm based on swarm optimization for classifi-
cation problems, termed multi-objective particle swarm 
optimization RBF network (MPSON). The results indi-
cated that this method had good generalization capabil-
ity along with compact network structure. Runkler et al. 
[66] made efforts to minimize fuzzy c-means model using 
ACO, alternate optimization (AO), and PSO. They sug-
gested two different forms of PSO: the first was PSO–V 
for representing particle as a component of a cluster 
center; the second was PSO–U for representing particle 
as a non-scaled and non-normalized membership value. 
PSO–V and PSO–U were compared with AO and ACO. 
They were compared with two different datasets: single 
outlier and lung cancer. The results of ACO, PSO–V, and 
PSO–U were slower than AO, but PSO variants outper-
formed significantly after each round of iteration. Liu 
et al. [67] suggested discrete particle swarm optimization 
(DPSO) and rule pruning for lung cancer diagnosis and 
achieved 68.3% classification accuracy. Liu et al. [68] used 
the PSO-based simultaneous learning framework for 
clustering and classification (PSOSLCC). PSOSLCC was 
applied to a real-world application, namely texture image 
segmentation, and good performance was obtained, 
showing that it could potentially classify problems on a 
large scale. Chen et al. [69] proposed an approach based 
on PSO with a decision tree classifier for statistical analy-
sis. They found that this method outperformed other 
popular classifiers (i.e., SVM, self-organizing map, back 
propagation neural network, and C4.5 decision tree) by 
conducting experiments on 11 gene expression cancer 
datasets. Subbulakshmi et  al. [70] proposed an efficient 
hybrid approach based on PSO with an extreme learning 
machine classifier. It had self-regulated learning capabil-
ity that showed good generalization performance. These 
studies above suggested that the data mining and evo-
lutionary algorithms both are efficient in lung cancer 
detection; while the evolutionary algorithms have the 
capabilities of handling complex problems, the data min-
ing algorithms alone may fail. Therefore, combining both 
approaches at different levels of classification and cluster-
ing may produce better outcomes.
The use of tobacco products causes approximately 5 
million deaths worldwide annually, with 2.41 million 
deaths in developing countries and 2.43 million deaths 
in developed countries [71–73]. Of the 5 million deaths 
that occurred annually in India, approximately 1 million 
could be attributed to cancer [71, 74]; by 2020, this figure 
is estimated to reach 1.5 million [40]. Smoking is respon-
sible for 80.0% of the lung cancer incidences worldwide 
[71–74]. In India, cigarette or beedi smoking causes the 
majority of the deaths in the 25–69 age group [71, 75]. 
Some studies have reported that 15.0% of lung cancer 
cases were caused by genetic factors, air pollution, or 
exposure to radon gas, asbestos, and pesticides [71, 76, 
77]. These studies also showed that, Indian non-smokers 
have almost the same chance of getting lung cancer as 
smokers because of exposure to pesticides and other car-
cinogens (Fig. 8) [36, 77]. Our results suggest that there 
must be strict restrictions on the use of tobacco products.
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Study limitations and future directions
This study has some limitations. Firstly, maximum col-
lection of data was based on the continuous availability 
of data, but in some cases the data were from one-time 
community- or hospital-based surveys. The incidence 
and mortality data from India and Egypt may not be 
complete. Therefore, deviations in incidence and mor-
tality from the actual are possible. However, these errors 
may be negligible, since as much data as possible were 
taken from identified sources and published papers. Sec-
ondly, we considered lung cancer statistics only from 
the UK, the US, India, and Egypt. The results will vary if 
more countries are considered. Thirdly, further research 
is required to clarify how data mining and evolutionary 
algorithms can be used together, and which combined 
techniques will be most effective. Finally, only English-
language sources and publications were examined.
Conclusions
In developed countries, such as the UK and the US, lung 
cancer mortality is declining and a high survival rate has 
been achieved, likely due to awareness programs and 
advanced medical technologies. However, in developing 
countries such as India and Egypt, substantial efforts are 
need to decrease cancer mortality.
We also analyzed computational methodologies for 
their usefulness in the early detection of lung cancer. It 
was found that data mining techniques such as classifi-
cation, clustering, and association rule mining were most 
commonly used but a better outcome could be achieved 
if data mining is combined with the evolutionary algo-
rithms. We also found that when lung cancer symp-
toms were identified correctly, the chances of detection 
increased; and for this classification, clustering tech-
niques of data mining could be employed. The chances 
of getting good results are lower with a single method, 
since the characteristics of lung cancer may be different. 
Data mining along with evolutionary algorithms can bet-
ter characterize lung cancer symptoms at different levels, 
arrange them in groups, and determine rankings to allow 
their stage and behavior being identified correctly and 
timely.
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